BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8865694)

  • 21. Progressive dystonia with marked diurnal fluctuation.
    Satishchandra P; Mullati N; Suresh TG
    J Assoc Physicians India; 1992 Jan; 40(1):55-6. PubMed ID: 1634470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Oculogyric crisis as an initial symptom of juvenile parkinsonism-like disease].
    Furumoto H; Kitano K; Wang DS; Matsumoto S; Moroo I
    Rinsho Shinkeigaku; 1989 Oct; 29(10):1287-9. PubMed ID: 2605835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Dopa-sensitive muscular dystonia. Segawa's syndrome. A case report].
    Giroud M; Septien L; Couillault G; Gras P; Nivelon JL; Dumas R
    Ann Pediatr (Paris); 1992 Apr; 39(4):248-50. PubMed ID: 1616238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hereditary progressive dystonia with marked diurnal fluctuation--a report of two siblings, one of them showing age-dependent changes of symptoms].
    Iwami O; Kawamura J; Hashimoto S; Suenaga T; Nakamura M
    Rinsho Shinkeigaku; 1990 Sep; 30(9):961-5. PubMed ID: 2265506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parkinsonism without dopamine neuron degeneration in aged l-dopa-responsive dystonia knockin mice.
    Rose SJ; Harrast P; Donsante C; Fan X; Joers V; Tansey MG; Jinnah HA; Hess EJ
    Mov Disord; 2017 Dec; 32(12):1694-1700. PubMed ID: 28949038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The deterioration of patients with parkinsonism treated with L-dopa].
    Guillard A
    Nouv Presse Med; 1975 Oct; 4(35):2503-6. PubMed ID: 1196872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hereditary dystonia-parkinsonism syndrome of juvenile onset.
    Nygaard TG; Duvoisin RC
    Neurology; 1986 Nov; 36(11):1424-8. PubMed ID: 3762960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Continuous levodopa infusions to treat complex dystonia in Parkinson's disease.
    Sage JI; McHale DM; Sonsalla P; Vitagliano D; Heikkila RE
    Neurology; 1989 Jul; 39(7):888-91. PubMed ID: 2472582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Unusual symptoms in Parkinsonism: positive effects of L-dopa].
    Morel-Maroger A; Therme F
    Therapie; 1978; 33(1):129-30. PubMed ID: 663891
    [No Abstract]   [Full Text] [Related]  

  • 30. Symptomatic dystonia: clinical profile of 46 Brazilian patients.
    Ferraz HB; Andrade LA
    Can J Neurol Sci; 1992 Nov; 19(4):504-7. PubMed ID: 1423047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Use of the preparation L-dopa in parkinsonism].
    Proniv DI; Sirotina OS; Bukhovtsev PP; Mis'kiv IaI
    Vrach Delo; 1976 Jan; (1):113-6. PubMed ID: 1246837
    [No Abstract]   [Full Text] [Related]  

  • 32. [Therapy of parkinsonism using L-Dopa (Brocadopa)].
    Jörg J
    Med Welt; 1975 Jan; 26(3):124-6. PubMed ID: 1110622
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effects and side effects of levodopa in parkinsonism - results of a collaborative study. (2) The relationship between the age of the onset and therapeutic effects].
    Yokochi M
    Rinsho Shinkeigaku; 1976 Dec; 16(12):871-3. PubMed ID: 1035528
    [No Abstract]   [Full Text] [Related]  

  • 34. [Correlation of clinico-physiologic indices and the serotonin content of the blood of patients with parkinsonism].
    Karimova MKh; Petelin LS; Aleuov ShA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(10):50-2. PubMed ID: 3213330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical and psychometric observations on the use of S-adenosylmethionine in parkinsonism during chronic L-dopa treatment].
    Megna G; Pennetta R; Andreula C
    Acta Neurol (Napoli); 1977; 32(2):204-17. PubMed ID: 930659
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of L-dopa on EEG tracings in patients with parkinsonism].
    Rudkowska A; Misztal S
    Pol Tyg Lek; 1975 Apr; 30(14):593-5. PubMed ID: 1129202
    [No Abstract]   [Full Text] [Related]  

  • 37. [Results of L-dopa treatment in parkinsonism (author's transl)].
    Kolasa M; Reichowa J; Bieniowa A
    Przegl Lek; 1976; 33(3):407-10. PubMed ID: 1273335
    [No Abstract]   [Full Text] [Related]  

  • 38. [Toloxatone, parkinsonism and dopa therapy].
    Cantagrel A; Dordain G; Dostert P
    Therapie; 1986; 41(6):493-7. PubMed ID: 3810545
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment of parkinsonism by dopaflex (L-DOPA).
    Grbesa B; Velicković A
    Ther Hung; 1977; 25(3):106-8. PubMed ID: 929475
    [No Abstract]   [Full Text] [Related]  

  • 40. The pharmacology of foot dystonia in parkinsonism.
    Poewe WH; Lees AJ
    Clin Neuropharmacol; 1987; 10(1):47-56. PubMed ID: 3545460
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.